Pathologic Complete Response to Preoperative Sequential Doxorubicin/Cyclophosphamide and Single-Agent Taxane With or Without Trastuzumab in Stage II/III HER2-Positive Breast Cancer
Saranya Chumsri(Jacksonville College), Vered Stearns(Johns Hopkins University), Hind Nassar(Johns Hopkins University), John H. Fetting(Johns Hopkins University), Richard C. Zellars(The University of Texas at San Antonio Health Science Center), Antonio C. Wolff(Johns Hopkins University), Lisa K. Jacobs(Johns Hopkins University), Theodore N. Tsangaris(Georgetown University), Deborah K. Armstrong(Johns Hopkins University), Zhe Zhang(Ningbo No. 2 Hospital), Julie R. Lange(Johns Hopkins Medicine), Carol Riley(Sidney Kimmel Comprehensive Cancer Center), Stacie C. Jeter(Johns Hopkins University), Leisha A. Emens(Johns Hopkins University)
Cited by 17
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)
|Archives of Pathology & Laboratory Medicine|2010|1.1k
CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment
|JNCI Journal of the National Cancer Institute|2005|947